Stocks360

Forward Pharma A/S (FWPAY)

Stock analysis · OTC · Healthcare · Biotechnology

Share: Facebook X WhatsApp SMS
$300.00

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$7.45M
PE (TTM)
-3.88
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
1.02
Day Range
$300.00 – $300.00
52-wk Range
$200.00 – $882.86
Avg Volume
N/A
Volume
4.00

Forward Pharma A/S (FWPAY) is a publicly traded company in the Healthcare sector. Latest price: $300.00. Market cap $7.45M. Trailing PE -3.88. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Earnings

Most Recent
Apr 18, 2017
EPS $-1.75 vs est. $-2.12
Beat by $0.37

Proprietary Signals

Signal snapshot temporarily unavailable.

About Forward Pharma A/S

Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions. The company was founded in 2005 and its headquarters are located in Copenhagen, Denmark.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-3.88×
P/S (TTM)0.00×
P/B0.10×
PEG0.05×
P/FCF (TTM)-3.16×
EV / EBITDA33.47×
EV / Sales0.00×
Earnings Yield-25.80%
Free Cash Flow Yield-31.68%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value-$63.32M
Net Income (TTM)-$1.92M
Free Cash Flow (TTM)-$2.36M
Net Debt-$70.77M
Working Capital$70.79M
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity-2.53%
Return on Invested Capital-5.47%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap